Reduction of myocardial infarct size with sCR1sLe(x), an alternatively glycosylated form of human soluable complement receptor type 1 (sCR1), possessing sialyl Lewis X. - Zacharowski,K.; Otto,M.; Hafner,G.; Marsh,H.C.; Thiemermann,C. (Br J Pharmacol, 1999)